MHRA: response to the termination of the BART Study on the use of aprotinin (Trasylol)
Aprotinin (Trasylol) is indicated for the prevention of major blood loss during coronary artery bypass graft surgery.
more ...
Sunday, 4 November 2007
Archive
-
▼
2007
(105)
-
▼
November
(11)
- MHRA: Aprotinin (Trasylol)
- AAGBI: Potential hazard during prone anaesthesia
- SG: NHS Consultant recruitment
- RCoA: Advance notice of changes to the FRCA examin...
- RCoA: MMC England e-update - 20 November 2007
- RCoA: Re-use of intravenous infusion equipment
- AAGBI: The GAT committee has submitted a response ...
- AAGBI: Staff and Associate Specialist Grades
- BMA: Doctors and nurses issue new guidelines on de...
- AAGBI: GAT committee response to DOH/MMC document
- MHRA: response to the termination of the BART Stud...
-
▼
November
(11)